Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
This article was originally published in The Tan Sheet
Executive Summary
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation
You may also be interested in...
J&J Washes Hands Of Purell As GOJO Eyes Consumer Segment Growth
Johnson & Johnson sells the Purell Hand Sanitizer brand, marking a major consumer health product divestment as the firm seeks to rebound from a troubled year for its consumer business.
J&J Washes Hands Of Purell As GOJO Eyes Consumer Segment Growth
Johnson & Johnson sells the Purell Hand Sanitizer brand, marking a major consumer health product divestment as the firm seeks to rebound from a troubled year for its consumer business.
J&J Washes Hands Of Purell As GOJO Eyes Consumer Segment Growth
Johnson & Johnson sells the Purell Hand Sanitizer brand, marking a major consumer health product divestment as the firm seeks to rebound from a troubled year for its consumer business.